Show items per page
Elements: 96
Page 1 on 5
 TitleAuthors / EditorsDate
add to browser selection
Effectiveness and safety of insulin glargine 300 U/mL in insulin-naïve patients with type 2 diabetes after failure of oral therapy in a real-world setting Pfohl, Martin; Jornayvaz, François; Fritsche, Andreas; Pscherer, Stefan; ... Seufert, Jochen 2020
add to browser selection
La NASH: une complication moins connue mais importante du diabète Gariani, Karim; Jornayvaz, François 2020
add to browser selection
Quelle place pour les inhibiteurs de la DPP-4 en 2020? Caironi, Verdiana; Jornayvaz, François; Gariani, Karim 2020
add to browser selection
Diabète: et si on se mettait à la place du patient? Wojtusciszyn, Anne; Jornayvaz, François 2020
add to browser selection
Diabète après transplantation rénale : mise au point Gariani, Karim; Jornayvaz, François; Hadaya, Karine 2020
add to browser selection
Diabétologie Jornayvaz, François; Gariani, Karim 2020
add to browser selection
The GLP-1R agonist liraglutide limits hepatic lipotoxicity and inflammatory response in mice fed a methionine-choline deficient diet Somm, Emmanuel; Montandon, Sophie Anne; Loizides-Mangold, Ursula Elfriede; Gaia, Nadia; ... Jornayvaz, François 2020
add to browser selection
Thirteen-year trends in the prevalence of diabetes according to socioeconomic condition and cardiovascular risk factors in a swiss population de Mestral, Carlos; Stringhini, Silvia; Guessous, Idris; Jornayvaz, François 2020
add to browser selection
Real-World Effectiveness of Insulin Glargine 300 Initiation in Switzerland Thomann, Robert; Zechmann, Stefan; Alexander-David, Nicola; Jornayvaz, François 2020
add to browser selection
Ulcère du pied chez un patient avec un diabète : quelle prise en charge médico-chirurgicale ? Mohamad, Morad; Pham, Truong-Thanh; Jornayvaz, François; Pignel, Rodrigue; ... Suva, Domizio 2020
add to browser selection
Multi-technique comparison of atherogenic and MCD NASH models highlights changes in sphingolipid metabolism Montandon, Sophie; Somm, Emmanuel; Loizides-Mangold, Ursula; De Vito, Claudio; ... Jornayvaz, François 2019
add to browser selection
Thirteen-year trends in the prevalence of diabetes in an urban region of Switzerland: a population-based study De Mestral, Carlos; Stringhini, Silvia; Guessous, Idris; Jornayvaz, François 2019
add to browser selection
Salivary cortisol is not associated with incident insulin resistance or type 2 diabetes mellitus Gariani, Karim; Marques-Vidal, Pedro; Waeber, Gérard; Vollenweider, Peter; Jornayvaz, François 2019
add to browser selection
Insuffisance rénale chronique et nouveaux traitements antidiabétiques : tour d’horizon en 2019 Andrade Lopes, Stéphanie; Jornayvaz, François; De Seigneux Matthey, Sophie 2019
add to browser selection
Faut-il prescrire plus d’inhibiteurs SGLT-2 ? Philippe, Jacques; Jornayvaz, François 2019
add to browser selection
[News in diabetology 2018] Jornayvaz, François 2019
add to browser selection
Nonalcoholic fatty liver disease burden Goossens, Nicolas; Bellentani, Stefano; Cerny, Andreas; Dufour, Jean-François; ... Semela, David 2019
add to browser selection
An Overview on Diabetic Foot Infections, including Issues Related to Associated Pain, Hyperglycemia and Limb Ischemia Uckay, Ilker; Jornayvaz, François; Lebowitz, Dan; Gastaldi, Giacomo Gianni Giuseppe; ... Lipsky, Benjamin Alan 2018
add to browser selection
Observance thérapeutique et empilage médicamenteux Jornayvaz, François; Philippe, Jacques 2018
add to browser selection
Diabétologie Jornayvaz, François 2018
<< previous | 1 | 2 | 3 | 4 | 5 |